Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 4Nasopharyngeal Carcinoma 3Esophageal Neoplasms 3Colorectal Neoplasms 3Barrett Esophagus 2Urogenital Neoplasms 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Lung Neoplasms 1Locally Advanced Pancreatic Cancer 1Jaw Cysts 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Colitis 1Carcinoma, Non-Small-Cell Lung 1Bacteremia 1

Interventions

Gemcitabine 4130-nm albumin-bound paclitaxel 2Tomography, X-Ray Computed 1Pancreatectomy 1Endoscopy 1Electroporation 1Drug Therapy 1Diagnostic Imaging 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Locally Advanced Pancreatic Cancer × Endoscopy × Clear all
NCT06944587 2025-04-25

NORPACT-3

Oslo University Hospital

Recruiting
400 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡